Showing results (31-40 of 239) with videos related to
Sort By:
Pageof 24
Cancer Research|December 24, 2009
CCL2 blockade augments cancer immunotherapyZvi G Fridlender, George Buchlis, Veena Kapoor, et al.Trends in Immunology|June 5, 2019
Neutrophil Diversity in Health and DiseaseCarlos Silvestre-Roig, Zvi G Fridlender, Michael Glogauer, et al.Cancer Research|December 17, 2008
Systemic blockade of transforming growth factor-beta signaling augments the efficacy of immunogene therapySamuel Kim, George Buchlis, Zvi G Fridlender, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|October 20, 2011
Treating tumors with a vaccinia virus expressing IFNβ illustrates the complex relationships between oncolytic ability and immunogenicityLiang-Chuan S Wang, Rachel C Lynn, Guanjun Cheng, et al.Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|May 6, 2024
Is there a role for lung or bronchial biopsies for the diagnosis of mycobacterial pulmonary disease in patients with bronchiectasis?Rottem Kuint, Avraham Abutbul, Zvi G Fridlender, et al.Journal of Cellular Immunology|September 11, 2020
Current Advances in CAR T Cell Therapy for Malignant MesotheliomaAstero Klampatsa, Steven M AlbeldaCancer Discovery|December 5, 2018
Molecular Characterization of Malignant Mesothelioma: Time for New Targets?Charu Aggarwal, Steven M AlbeldaPlos One|March 3, 2017
The association between osteopontin gene polymorphisms, osteopontin expression and sarcoidosisHadas Lavi, Miri Assayag, Assaf Schwartz, et al.Oncoimmunology|July 3, 2015
Splenectomy inhibits non-small cell lung cancer growth by modulating anti-tumor adaptive and innate immune responseLiran Levy, Inbal Mishalian, Rachel Bayuch, et al.Respiratory Medicine|May 1, 2010
Association between CD14 gene polymorphisms and disease phenotype in sarcoidosisZvi G Fridlender, Asaf Schwartz, Martin Kohan, et al.Pageof 24